Cardalis - When to Utilize RAAS Suppression and Why
Nov 09, 2023
![Cardalis - When to Utilize RAAS Suppression and Why](https://taskfilescsm.s3.amazonaws.com:443/uploads/speaker_thumb/2023-08-2513%253A15%253A42136726-Logo4colors.jpg)
It has been over 2 and 1/2 years since CARDALIS ® was FDA-approved for dogs with
symptomatic chronic degenerative valve disease. The combination of Benazepril and
Spironolactone in CARDALIS™ provides a unique combination of active ingredients to block
the effects of the RAAS cascade. These active ingredients are recommended by the ACVIM to
treat CHF at the onset of signs.